Novonesis AS

Transaction in Own Shares • Mar 16, 2015

March 16, 2015

As of March 13, Novozymes has purchased an accumulated 1,000,000 shares with a transaction value of DKK 312.5 million under the stock buyback program Novozymes announced in Company announcement No. 6, 2015 and initiated February 2, 2015. Under the program, Novozymes will buy back B shares worth up to DKK 2 billion in total during 2015.

The following transactions have been made under the program in accordance with the provisions of European Commission Regulation (EC) No. 2273/2003 of 22 December 2003, also referred to as the Safe Harbour Regulation:

	Number of shares	Average purchase price	Transaction value, DKK
Accumulated, last announcement	878,000		273,717,004
9 March 2015	25,000	315.71	7,892,723
10 March 2015	25,000	314.67	7,866,716
11 March 2015	27,000	316.74	8,551,957
12 March 2015	25,000	320.14	8,003,500
13 March 2015	20,000	322.01	6,440,210
Accumulated under the program	1,000,000		312,472,110

In addition, transactions necessitated by Novozymes' previously established incentive programs have resulted in a net sale by Novozymes of 5,283 B shares in the period from March 9 to March 13, 2015. The share transactions related to the incentive programs were not part of the Safe Harbour stock buyback program.

Following the transactions stated above, Novozymes owns a total of 11,682,497 treasury shares, corresponding to 3.7% of the stock capital. The total number of shares in the company is 319,700,000, including treasury shares.

Contact information

Investor Relations:
Thomas Bomhoff (DK)	+45 3077 1226	tsbm@novozymes.com
Klaus Sindahl (DK)	+45 5363 0134	ksdh@novozymes.com
Martin Riise (USA)	+1 919 649 2565	mrsn@novozymes.com

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.